• 

• CAS 59092-91-0 Albaspidin AP

  Description Syringin is a phenylpropanoid glycoside first isolated from A. senticosus that enhances acetylcholine release in pancreatic cells leading to an increase in insulin release through the muscarinic M3 receptor. Syringin dose-dependently (50, 75, and 100 μg/kg, i.v.) decreases plasma glucose levels and increases insulin-like immunoreactivity and C-peptide in rats, and these effects last at least 60 minutes. In a rat model of type 1 diabetes, it decreases plasma glucose and increases β-endorphin release from the adrenal medulla. Syringin increases autophagy through AMP-activated protein kinase α (AMPKα) activation concomitant with preventing the progression of cardiac hypertrophy in mice following aortic banding. It also has immunomodulatory effects, likely due to its metabolite sinapyl alcohol.

  
  

  
  

  Price on request

  REQUEST NOW

Product Introduction:

Product Name: Albaspidin AP

Synonyms: 2,5-Cyclohexadien-1-one,2-[(5-acetyl-2,4- dihydroxy-3,3-dimethyl-6-oxo-1,4-cyclohexadien- 1-yl)methyl]-3,5-dihydroxy-4,4- dimethyl-6-(1-oxopropyl)-;Albaspidin AP

CAS: 59092-91-0

MF: C22H26O8

MW: 418.44

Product Categories: chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract